Net revenue grew 3.5% to CHF 582.7 million in H1 2026, with organic growth at 4.6% and EBIT margin up to 13%. Healthcare drove growth with a 9.5% organic increase, while the Capsul'in acquisition contributed to both revenue and margin gains. Midterm targets and positive outlook reaffirmed.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.